QCR Global Group and DMO Consulting Form A Global Partnership

NEW YORK - Aug. 20, 2015 - PRLog -- QCR Global Group, a management consulting and communication company providing innovative niche services to the biopharmaceutical industry. Announced their exclusive partnership with DMO Consulting a medical affairs and journalism company.  QCR Global will work together with DMO Consulting to expand their presence in providing medical affairs and communication services by redefining their niche business and addressing key industry challenges to spark true business change—grounded in their new core capabilities:

▪     A new class of industry specific enterprise solutions including creating a market unit strategically targeting emerging and developing countries. The service will aim to increase potential and current client presence in these markets, while expanding patient access to global medicinal products and vaccines.  The service will also help to provide their clients a means to also establish a long-term presence recognizable by their key consumers.

▪     Improving key opinion leader engagement and partnering with key stakeholders to account for different standards used to manage patient needs. The service will extend from its traditional market in North America and the EU. To the emerging and developing countries, adding tangible value to patients, patient caregivers and their healthcare providers.

▪   Integrated medical data and analytics tailored to a client specialty product or brand. The service will work to expand and improve expert peer recognition of credible and unbiased scientific information related to the specialty brand markets. Targeting consumer friendly material, medical conference material and scientific publications. 


▪   A robust compliance and SOP program to help our clients develop clear cut policies for on and off label inquiries, wherever the client product has a global market presence. The program will help to develop and implement mechanisms needed to avoid risk and maintain organizational standards due to the shift in medical affairs responsibilities occurring at present and expected to increase in the future.

These services will be built in an exclusive collaboration that draws on the distinct strengths of each company: QCR’s expert biopharmaceutical consultants, promotional communication and strategic data and analytics capabilities, with DMO’s worldwide medical communications, and global regulatory experts behind it. The collaboration will also fuse QCRs patient advocacy partnering and compliance planning expertise. These services will allow companies to better manage risk, and take advantage of opportunities not yet exhausted in the marketplace. Resulting in new levels of effectiveness and customer satisfaction-more specialty product driven and more efficient than ever before.

QCR Global and DMO Consulting’s shared vision for this partnership is to work together to deliver the essential elements of enterprise medical affairs and communication solutions by:

-        Increasing Market Engagement: The two companies will collaborate to broaden clients’ portfolios making them better able to analyze and communicate their brands based on the needs of emerging and developing countries. This will also provide our clients the opportunity to experiment with tiered pricing and patient healthcare models. The collaboration with local country health agencies, key opinion leaders, patient advocacy groups and academic institutions will play an integral role in its success. This model is specific to industry future business and strategy. Stepping ahead of the usual European and US model being used now.

-        Improved Patient and Health Care Professional Engagement: By partnering with a broader range of healthcare stakeholders QCR Global Group and DMO Consulting will work to provide our clients analysis and expert information with the purpose of better understanding the different needs of patients. The service will help personalize patient management and focus on our client’s specialty brand positioning strategy and statements.

-        Integrated Data and Analytics-Facilitated coordination and integration of different medical data and scientific knowledge is part of the edge we bring to our clients with our added core services. The goal is that it will work to not only achieve proficiency in the communications shared with the consumer but also support external recognition by scientific thought leaders. Helping to provide credible and unbiased scientific information to the research community. 


-        Niche Medical Affairs Compliance Training- To reduce regulatory risk, clear cut policies and guidelines help companies embrace a proactive approach to medical affairs compliance. The field medical teams depend on having the necessary “sound bytes” from medical affairs to present their company’s product information. With the short time they are given and in consideration of the regulatory guidance of DDMAC and OIG regulations. This enterprising service fills a much needed gap often times unmet in the medical affairs division.

The consortium of core services provides a positive addition of niche biopharmaceutical solutions exclusive to the collaboration and drawing from the strengths of both companies. QCR Global Group will present details on the newly configured services at the Medical Affairs Strategic Summit and Society for Neuroscience meetings both being held in October 2015.

QCR a growing niche consultancy in biopharmaceutical management and medical communications started in 1999. Is known for providing specialized R & D operational management and medical affairs consulting, strategic medical communication counseling and optimizing key scientific expert networks.With a network of 200 consultant experts, QCR has positioned itself to work on enterprising its services to create better metrics for its innovational trends. Enabling their clients to streamline and accelerate newly invigorated client processes while formulating ideas to engage and better their client’s customer information. Resulting in a captured customer intelligence and improved market presence.

DMO Consulting a small global medical writing and journalism company with 8 years of expert hands on experience in the biopharmaceutical industry. Has grown to become a trusted advisor in the field to government, private and public sectors of industry. Thereby demonstrating recognition for its talent and expertise while serving the scientific community.

For more information regarding QCR Global Group, and DMO Consulting LLC., new core services and collaboration, please visit http://www.qcrglobal.com/services or http://www.dmoconsullting.com

PR Contacts: lgoodwin@qcrglobal.com

         snikyob@dmoconsulting.com